The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages

Blood

Volumn 95, Issue 4, 2000, Pages 1158-1166

  Scheuerer, Barbara ^a   Ernst, Martin ^a   Dürrbaum Landmann, Iris ^a   Fleischer, Jens ^a   Grage Griebenow, Evelin ^a   Brandt, Ernst ^a   Flad, Hans Dieter ^a   Petersen, Frank ^a  

^a Centre for Research Borstel   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CARBOXYPEPTIDASE; FRACTALKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; LIPOCORTIN 5; NEUTRALIZING ANTIBODY; RANTES; THROMBOCYTE FACTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MACROPHAGE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION;

EID: 0034651633     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.4.1158.004k31_1158_1166     Document Type: Article

References (43)

1. Niewiarowski S, Rucinski B, Budzynski AZ. Low affinity platelet factor 4 and high affinity platelet factor 4: two antiheparin factors secreted by human platelets. Thromb Haemost. 1979;42:1679.
2. Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA. Studies of human platelet α-release in vivo. Blood. 1981;58:607.
3. Kameyoshi Y, Dörschner A, Mallet AI. Christophers E, Schröder J-M. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils J Exp Med. 1992; 176:587.
4. Oppenheim JJ. Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol. 1991;9:617.
5. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol. 1994;55:97.
6. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 1997;15:675.
7. Petersen F, Ludwig A, Flad HD, Brandt E. TNF-α renders human neutrophils responsive to platelet factor 4: comparison of PF4 and IL-8 reveals different activity profiles of the two chemokines. J Immunol. 1996;156:1954.
8. Petersen F, Bock L, Flad H-D, Brandt E. A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation. J Immunol. 1998;161:4347.
9. Petersen F, Brandt E, Lindahl U, Spillmann D. Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4. J Biol Chem. 1999;274:12,376.
10. Brindley LL, Sweet JM, Goetzl EJ. Stimulation of histamine release from human basophils by human platelet factor 4. J Clin Invest. 1983;72:1218.
11. Hayashi N, Chihara J, Kobayashi Y, et al. Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion. Int Arch Allergy Immunol. 1994;104(suppl 1)(1):57.
12. Han ZC, Lu M, Li JM, et al. Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Blood. 1997;89:2328.
13. Han ZC, Bellucci S, Walz A, Baggiolini M, Caen JP. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III). Int J Cell Cloning. 1990;8:253.
14. Luster AD, Greenberg SM, Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med. 1995;182:219.
15. Watson JB, Getzler SB, Mosher DF. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. J Clin Invest. 1994;94: 261.
16. 165 using several concurrent mechanisms. J Biol Chem. 1995;270:15059.
17. Tanaka T, Manome Y, Wen P, Kufe DW, Fine HA. Viral vector-mediated transaction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nat Med. 1997;3:437.
18. Grage-Griebenow E, Lorenzan D, Fetting R, Flad H-D, Ernst M. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human subpopulation with high accessory and antiviral activity. Eur J Immunol. 1993;23:3126.
19. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Van Oers MHJ. Annexin-V for flow-cytometric detection of phosphatidylserine expression on B-cells undergoing apoptosis. Blood. 1994;84:1415.
20. Martin SJ, Reutlingsperger CPM, McGahon AJ, et al. Early redistribution of the plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545.
21. Heidenreich S, Schmidt M, August C, Cullen P, Rademaekers A, Pauels H-G. Regulation of human monocyte apoptosis by the CD14 molecule. J Immunol. 1997;159:3178.
22. Mangan DF, Welch GR, Wahl SM. Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol. 1991;146:1541.
23. Andreesen R, Bross KJ, Osterholz J, Emmerich F. Human macrophage maturation and heterogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens. Blood. 1986;67:1257.
24. Rehli M, Krause SW, Kreutz M, Andreesen R. Carboxypeptidase M is identical to the MAX . 1 antigen and its expression is associated with monocyte to macrophage differention. J Biol Chem. 1995;270:15,644.
25. Dürrbaum-Landmann I, Gercken J, Flad H-D, Ernst M. Effect of in vitro infection of human monocytes with low numbers of Mycobacterium tuberculosis bacteria on monocyte apoptosis. Infect Immun. 1996;64:5384.
26. Mangan DF, Wahl SM. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol. 1991;147:3408.
27. Becker S, Warren MK, Haskill S. Colony-stimulating factor induced monocyte survival and differentiation into macrophages in serum-free cultures. J Immunol. 1987;139:3703.
28. Imoto M, Yoshimura H, Yamamoto M, Shimamota T, Kusumota S, Shiba T. Chemical synthesis of phosphorylated tetraacyl disaccharide correspending to a biosynthetic precursor of lipid A. Tetrahedron Lett. 1984;25:2667.
29. Zembala M, Asherson GL. Human Monocytes. New York, NY: Academic Press; 1989.
30. Zuckerman SH, Ackerman SK, Douglas SD. Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology and primary human monocyte-macrophage cell cultures. Immunology. 1979;38:401.
31. 3. Blood. 1990;76:2457.
32. Geissler K, Harrington M, Srivastava C, Leemhuis T, Tricot G, Broxmeyer HE. Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation. J Immunol. 1989;143:140.
33. Tsai V, Firestein GS, Arend W, Zvaifler NJ. Cytokine-induced differentiation of cultured nonadherent macrophages. Cell Immunol. 1992;144:203.
34. Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER. Activated platelets express IL-1 activity. J Immunol. 1989;143:4015.
35. Ammon C, Kreutz M, Rehli M, Krause SW, Andreesen R. Platelets induce monocyte differentiation in serum-free coculture. J Leukoc Biol. 1998; 63:469.
36. Levine SP, Krentz LS. Development of a radioimmunoassay for human platelet factor 4. Thromb Res. 1977;11:673.
37. Nagata S. Apoptosis by death factor. Cell. 1997; 88:355.
38. Um H-D, Orenstein JM, Wahl SM. Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol. 1996;156:3469.
39. Kiener PA, Davis PM, Starling GC, et al. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J Exp Med. 1997;185:1511.
40. Grage-Griebenow E, Baran J, Loppnow H, et al. An Fcγ receptor I (CD64)-negative subpopulation of human peripheral blood monocytes is resistant to killing by antigen-activated CD4-positive cytotoxic T cells. Eur J Immunol. 1997;27:2358.
41. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol. 1993;11:191.
42. Azuma M, Yagita H, Okumura K, Phillips JH, Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature. 1993;366:76.
43. Creery WD, Diaz-Mitoma F, Filion L, Kumar A. Differential modulation of B7-1 and B7-2 isoform expression on human morocytes by cytokines which influence the development of T helper cell phenotype. Eur J Immunol. 1996;26:1273.